Your browser doesn't support javascript.
loading
Serum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report.
Chen, Zhiheng; Guan, Hong; Yuan, Hong; Cao, Xia; Liu, Yingxin; Zhou, J I; He, Ellen; Skog, Sven.
Affiliation
  • Chen Z; Health Management Centre, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
  • Guan H; Department of Pathology, Shenzhen Second Hospital, Shenzhen, Guangdong 322000, P.R. China.
  • Yuan H; Research Center of Sub-Health's Diagnose and Intervention Technology and Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
  • Cao X; Health Management Centre, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
  • Liu Y; Health Management Centre, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
  • Zhou JI; Sino-Swed Molecular Bio-Medicine Research Institute, Shenzhen, Guangdong 518057, P.R. China.
  • He E; Sino-Swed Molecular Bio-Medicine Research Institute, Shenzhen, Guangdong 518057, P.R. China.
  • Skog S; Sino-Swed Molecular Bio-Medicine Research Institute, Shenzhen, Guangdong 518057, P.R. China.
Oncol Lett ; 10(3): 1669-1673, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26622729

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Oncol Lett Year: 2015 Document type: Article Country of publication: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Oncol Lett Year: 2015 Document type: Article Country of publication: Greece